Matrixx Runs on Stock Tout (MTXX)
Matrixx Initiatives Inc. (NASDAQ: MTXX) has no real fresh news. This week it did elect a new CEO but this morning there was a stock tout from one of the Najarian brothers of OptionsMonster.com on CNBC. What was noted is the options trading picked up this week as institutions are betting that the Zicam nasal [...]
Volume Back Up in Human Genome Sciences (HGSI)
Human Genome Sciences Inc. (NASDAQ: HGSI) is trading higher this morning, and it doesn’t seem to be tied to those pesky buyout or merger rumors that were persisting for a couple of weeks. The company announced that a medical journal published positive comments concerning its lupus drug candidate, which may be like reporting from the [...]
No Good Day at Array (ARRY)
Array BioPharma Inc. (NASDAQ: ARRY) was whacked after the emerging drug and biotech player said its experimental rheumatoid arthritis treatment study failed to meet its endpoints and was not more effective than the placebo in reducing symptoms. At 9:05 AM EST we have already seen 350,000 shares trade hands versus an average volume of about [...]
Novellus Jumps on Orders Data
Novellus Systems, Inc. (NASDAQ: NVLS) is showing that semiconductor cap-ex is also starting to come back online after it raised its new orders guidance from a base-line of what was +20% to a higher base of +40%. Shares are up right at 4% at $19.81 as of 9:00 AM EST on 112,000 shares of stock. [...]
VS Investor RSS Feed